Most Recent
Westpac's shuttered home loan unit RAMS may hit back at franchisees' class action claims by alleging they made misrepresentations and provided fraudulent documents.
Medical device supplier Medtronic has been socked with a $22 million penalty after it supplied non-compliant bone graft kits to hospitals, in what is the largest penalty under the Therapeutics Good Act.
Mastercard is fighting an evidentiary win for the competition watchdog in a case alleging the payments giant misused its market power in deals with major retailers.
A $100 million settlement by AMP in a class action by financial planners over the wealth manager's buyer of last resort policy has been given the OK, but the litigation funder won't be reimbursed for $2.6 million in insurance and administrative costs.
A judge has ordered credit card giant American Express to pay $8 million in ASIC’s first-ever case over design and distribution obligations, but has criticised the recently enacted provisions as being “poorly drafted”.
Westpac subsidiary RAMS has flagged a cross-claim against disgruntled franchisees who say their agreements were terminated without proper cause, citing possible breaches of the National Credit Act.
Westpac subsidiary RAMs has been hit with a class action by former franchisees who say their agreements with the home loan provider were terminated without proper cause.
Five passengers who were forced off a Qatar Airways flight and strip searched at Doha International Aiport have appealed a ruling summarily tossing their claims against the airline.
Dental aligner maker Invisalign has won an appeal of a decision rejecting its case accusing SmileDirectClub of misleading consumers, but the appeals court noted that the prospect of a new trial was “remote” after its competitor went under.
A judge has summarily dismissed a case by five passengers against Qatar Airways that alleged the airline was liable for invasive examinations conducted by Qatar police after a newborn baby was found in a bin at the Doha airport. But the case is allowed to continue against subsidiary MATAR.